Physician profile
Nicole Clegg
NPI 1033873450
$1,107.39
in general payments reported to CMS, 2019-2025
17 companies · $495 in 2025
The $495 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.65 · 2022: $48.28 · 2023: $202 · 2024: $349 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,046.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $307.63 | 2023-2025 | Airsupra, Breztri, Evusheld |
| Xeris Pharmaceuticals, INC. | $143.51 | 2023-2025 | Keveyis, Gvoke Hypopen |
| Exact Sciences Corporation | $111.92 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $91.02 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $83.26 | 2022-2024 | Shingrix, Trelegy Ellipta, Boostrix |
| Pfizer INC. | $71.45 | 2025 | |
| Sumitomo Pharma America, INC. | $57.35 | 2024-2025 | Gemtesa |
| Astellas Pharma US INC | $43.45 | 2024 | Veozah |
| Amgen INC. | $42.02 | 2024-2025 | Otezla, Repatha, Otezla |
| Ars Pharmaceuticals Operations, INC. | $26.27 | 2025 | Neffy |
| Ani Pharmaceuticals, INC. | $24.93 | 2024 | Purified Cortrophin Gel |
| Abbvie INC. | $24.50 | 2023 | |
| Lilly USA, LLC | $24.31 | 2025 | Zepbound, Mounjaro |
| Horizon Therapeutics Plc | $16.49 | 2023 | Krystexxa |
| Lucid Diagnostics INC. | $15.19 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $12.65 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $11.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Clegg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.